Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2082891 | Drug Discovery Today: Therapeutic Strategies | 2011 | 5 Pages |
Abstract
Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
David L. Roberts, Dawn I. Velligan,